Navigation

Head and Neck Cancer

Note: The information on cancer types on the ACRF website is not designed to provide medical or professional advice and is for information only. If you have any health problems or questions please consult your doctor. All statistics have been sourced from the Australian Institute of Health and Welfare.

ACRF & Head and Neck Cancer

To date, ACRF has provided 65 grants totalling $129.3 million to cancer research projects across Australia, investigating all cancers including head and neck cancer. To learn more about these projects click here.

Support cancer research

Head and Neck Cancer Statistics

  • Over 3,800 new head and neck cancers were diagnosed in Australia in 2009.
  • The most commonly diagnosed head and neck cancers are cancers of the lip, tongue and larynx.
  • All three of the above cancers were more common in males than females.
  • For more cancer statistics click here.

Head and Neck Cancer Overview

Head and neck cancer refers to a group of cancers that are biologically similar – starting in the lip, mouth, nasal cavity, sinuses, pharynx and larynx. These head and neck cancers are, in 90% of cases, squamous cell carcinomas, originating from the epithelial tissues which line the cavities and surfaces of these structures and organs.

The onset of head and neck cancers is strongly associated with environmental and behavioural factors, including smoking, alcohol consumption, exposure to UV light, toxic chemicals and viruses such as the human papillomavirus.

Head and neck cancers tend to be aggressive or fast-growing, however they can be cured if detected early, usually through surgery and/or radiotherapy.

Please click on the below for more information about types of head and neck cancers.

Cancers of the oesophagus, the brain, eye, scalp, skin and muscles of the head and neck are not considered ‘head and neck cancers’.

LATEST Cancer Research Updates | ACRF

Gene discovery to help breast cancer patients

Cancer researchers at QIMR Berghofer have discovered a set of genes that could be used to predict the survival of breast cancer…

Interleukin-2 immunotherapy improved

Researchers at the Garvan Institute of Medical Research have been exploring ways to make interleukin-2 (IL-2) immunotherapy less toxic and more effective against…

New ACRF research centre targets early detection of lung cancer

The ACRF Centre for Lung Cancer Early Detection has been officially launched today at The University of Queensland’s Thoracic Research Centre at…

Cancer Research Discoveries | ACRF

Gene discovery to help breast cancer patients

Cancer researchers at QIMR Berghofer have discovered a set of genes that could be used to predict the survival of breast cancer…

Interleukin-2 immunotherapy improved

Researchers at the Garvan Institute of Medical Research have been exploring ways to make interleukin-2 (IL-2) immunotherapy less toxic and more effective against…

Study raises hopes for new sarcoma treatment

Researchers at Monash University in Melbourne have played a critical role in an international collaboration that has identified promising therapeutic targets for…